MolDX welcomes the states of Georgia, Tennessee, and Alabama to the MolDX program and to Palmetto GBA

The MolDX team welcomes the states of Georgia, Tennessee, and Alabama to the MolDX program and to Palmetto GBA. Medicare Part A and Part B providers in the Palmetto GBA Jurisdiction J will be are required to register all molecular tests with the Diagnostics ExchangeTM (DEX), an online test registry. DEX Diagnostics ExchangeTM will assign a unique Z-Code identifier to each molecular test. After the registration and application processes have been completed, the MolDX team will access the registry information to determine if a test meets the Medicare criteria for coverage. For more detailed information about the MolDX program, please visit their website https://www.palmettogba.com/MolDX. MolDX strongly suggest labs and other test providers begin the process now to avoid any claim processing delays once the Z-code is required on the claim, which is currently projected to be no later than claims submitted on or after June 1, 2018.

Source: https://www.palmettogba.com/palmetto/MolDX.nsf/DocsCat/MolDx Website~MolDx~Browse By Topic~General~ARUNYM5417?open